GNRH1 and polycystic ovary syndrome: Stone and colleagues (2023) reported that the block of sex hormone production (GnRH antagonism) reduced aldosterone concentrations in PCOS but not in age‐, BMI‐ and insulin‐resistance‐matched controls (Stone et al., 2023), suggesting a role of androgens in RAAS activation in PCOS.